Soji Morishita

Hongo, 1138421, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Genomic insights transform diagnosis, prognosis, and therapy in BCR::ABL1-negative myeloproliferative neoplasms.

Genomic insights transform diagnosis, prognosis, and therapy in BCR::ABL1-negative myeloproliferative neoplasms.

Journal: International journal of hematology

Published: April 20, 2026

Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL.

Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL.

Journal: Haematologica

Published: February 12, 2025

Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution.

Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution.

Journal: International journal of hematology

Published: January 29, 2025

Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells.

Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells.

Journal: Cell death & disease

Published: December 01, 2024

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 15, 2024

Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation.

Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation.

Journal: Experimental hematology

Published: November 14, 2023

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.

Journal: British journal of haematology

Published: August 21, 2023

Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms.

Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms.

Journal: International journal of molecular sciences

Published: July 28, 2023

MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.

MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 28, 2023

Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.

Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.

Journal: Stem cell reports

Published: May 16, 2023

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Journal: International journal of hematology

Published: January 28, 2023

Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.

Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.

Journal: Journal of thrombosis and thrombolysis

Published: December 03, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026